A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: A competing-risks regression analysis

European Urology

Volumn 60, Issue 6, 2011, Pages 1152-1159

  Sun, Maxine ^a   Abdollah, Firas ^b   Bianchi, Marco ^a,b   Trinh, Quoc Dien ^a,c   Jeldres, Claudio ^a   Tian, Zhe ^a   Shariat, Shahrokh F ^d   Widmer, Hugues ^a   Zorn, Kevin ^a   Menon, Mani ^c   Montorsi, Francesco ^b   Perrotte, Paul ^a   Karakiewicz, Pierre I ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Age; Cancer specific mortality; Competing risks regression; Nephrectomy; Renal cell carcinoma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRADE FOR GRADE ANALYSIS; GROUPS BY AGE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; STAGE FOR STAGE ANALYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 80255131135     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.07.064     Document Type: Article

References (33)

1. M. Sun, R. Thuret, and F. Abdollah Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis Eur Urol 59 2011 135 141
2. A. Jemal, F. Bray, and M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
3. J.M. Hollingsworth, D.C. Miller, and S. Daignault Rising incidence of small renal masses: a need to reassess treatment effect J Natl Cancer Inst 98 2006 1331 1334 (Pubitemid 44530728)
4. U.S. interim projections by age, sex, race, and Hispanic origin: 2000-2050. 2011. US Census Bureau Web site. http://www.census.gov/population/ www/projections/usinterimproj.
5. B.J. Scoll, Y.-N. Wong, and B.L. Egleston Age, tumor size and relative survival of patients with localized renal cell carcinoma: a Surveillance, Epidemiology and End Results analysis J Urol 181 2009 506 511
6. M. Muramaki, H. Miyake, and I. Sakai Age at diagnosis as a powerful predictor for disease recurrence after radical nephrectomy in Japanese patients with pT1 renal cell carcinoma Int J Urol 18 2011 121 125
7. Y. Komai, Y. Fujii, and Y. Iimura Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma Urology 77 2011 842 847
8. P.I. Karakiewicz, C. Jeldres, and N. Suardi Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy Can Urol Assoc J 2 2008 610 617
9. P.I. Karakiewicz, N. Suardi, and U. Capitanio A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma Eur Urol 55 2009 287 295
10. J.M. Hollingsworth, D.C. Miller, and S. Daignault Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis Cancer 109 2007 1763 1768 (Pubitemid 46668538)
11. L. Sobin, M. Gospodarowicz, and C. Wittekind International Union Against Cancer (UICC). TNM classification of malignant tumors ed 6 2002 Wiley-Blackwell Oxford, UK
12. J. Fine, and R. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
13. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1140 1154
14. M. Pintilie Competing risks: a practical perspective 2006 John Wiley & Sons Hoboken, NJ
15. Bianchi M, Sun M, Jeldres C, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. In press.
16. L.C. Walter, and K.E. Covinsky Cancer screening in elderly patients: a framework for individualized decision making JAMA 285 2001 2750 2756 (Pubitemid 32525372)
17. S. Campbell, A. Novick, and A. Belldegrun Guideline for management of the clinical T1 renal mass J Urol 182 2009 1271 1279
18. Kidney cancer (cited V.2.2011). National Comprehensive Cancer Network Web site. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#site.
19. B. Ljungberg, N.C. Cowan, and D.C. Hanbury EAU guidelines on renal cell carcinoma: the 2010 update Eur Urol 58 2010 398 406
20. B.R. Lane, R. Abouassaly, and T. Gao Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older Cancer 116 2010 3119 3126
21. A. Volpe, J.A. Cadeddu, and A. Cestari Contemporary management of small renal masses Eur Urol 60 2011 501 515
22. G. Lughezzani, M. Sun, and L. Budäus Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma J Clin Oncol 28 2010 299 300
23. A. Kutikov, B.L. Egleston, and Y.-N. Wong Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram J Clin Oncol 28 2010 311 317
24. A. Zisman, A.J. Pantuck, and J. Wieder Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma J Clin Oncol 20 2002 4559 4566 (Pubitemid 35402959)
25. R.H. Thompson, B.C. Leibovich, and C.M. Lohse Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score J Urol 177 2007 477 480 (Pubitemid 46054015)
26. M.W. Kattan, V. Reuter, and R.J. Motzer A postoperative prognostic nomogram for renal cell carcinoma J Urol 166 2001 63 67 (Pubitemid 32565343)
27. R.F. Sánchez-Ortiz, C.J. Rosser, and L.T. Madsen Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma J Urol 171 2004 2160 2165 (Pubitemid 38625426)
28. E.-J. Jung, H.J. Lee, and C. Kwak Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma Urology 73 2009 137 141
29. R.H. Thompson, M.A. Ordonez, and A. Iasonos Renal cell carcinoma in young and old patients - is there a difference? J Urol 180 2008 1262 1266 discussion 1266
30. M.D. Gillett, J.C. Cheville, and R.J. Karnes Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses J Urol 173 2005 1893 1896 (Pubitemid 40675205)
31. P.E. Clark, and M.S. Cookson The von Hippel-Lindau gene: turning discovery into therapy Cancer 113 2008 1768 1778
32. T.K. Choueiri, F.A.B. Schutz, and N.D. Hevelone Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis Urology 78 2011 93 98
33. D.W. Lin, M. Porter, and B. Montgomery Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study Cancer 115 2009 2863 2871